查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571574

胜胜肽合成市场规模、份额和趋势分析报告：2024-2030 年按产品、应用、技术、最终用途、地区和细分市场进行的预测

Peptide Synthesis Market Size, Share & Trends Analysis Report By Product (Equipment, Reagents & Consumables), By Application (Therapeutics, Diagnosis), By Technology, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

胜胜肽合成市场成长与趋势：

Grand View Research, Inc.的最新报告显示，预计2030年全球胜肽合成市场规模将达到14亿美元，2024年至2030年复合年增长率为12.7%。

针对胜肽疗法开发的重大研究和创新将在不久的将来推动市场成长。此外，胜肽合成技术的不断进步预计将为在市场上企业发展的公司提供利润丰厚的机会。

近年来，客自订胜肽合成的需求激增，该行业的多家公司都提供与自订胜肽合成相关的产品和服务。例如，英国的 Almac Group 提供适合研究应用的胜胜肽合成。对客自订胜肽不断增长的需求和不断变化的市场格局将为市场成长提供利润丰厚的机会。供应商正在提高产能，以满足研究和治疗领域对高品质胜胜肽不断增长的需求。

製药公司对新型生技药品开发的日益关注以及胜胜肽药物从管道阶段向商业规模的转变将进一步加强市场成长。越来越多的研究活动探索高品质胜胜肽和胜肽库在疫苗开发和生物标记发现中的潜力，为全球胜肽合成市场的收益做出了重大贡献。此外，市场上引入具有增强稳定性和药物动力学特性的修饰胜肽（GMP胜肽）预计将在整个预测期内维持两位数的市场成长。

近年来，由于患有心血管和代谢疾病的患者数量显着增加，治疗性胜胜肽的开发经历了显着增长。这大大加速了生物活性胜胜肽的发现，进一步刺激了市场需求。

胜肽合成市场报告亮点

  • 试剂和耗材在 2023 年的收益最高，预计这一趋势将在预测期内持续下去。
  • 胜肽合成器在预测期内增长最快。
  • 胜胜肽合成仪领域对全球市场的设备收益贡献庞大，预计2024年至2030年复合年增长率将在其他胜胜肽合成仪中最高，达13.6%。
  • 液相胜肽合成 (LPPS) 技术预计将在 2023 年主导胜胜肽合成市场，并在整个预测期内继续保持这种主导地位。
  • 预计治疗性胜胜肽合成将在 2023 年占据市场最大份额，并在整个预测期内保持这一趋势。
  • 北美地区在 2023 年的收益最高，预计在整个预测期内将保持这一主导地位。大量熟练的专业人员以及强大的胜胜肽合成製造商网路有助于该地区在全球市场中占据主导地位。
  • 由于越来越重视开拓胜肽疗法的新兴市场，预计亚太地区将提供市场扩张的机会。
  • 亚太地区心血管和代谢疾病患者人数众多，对收益贡献巨大，导致预测期内复合年增长率最高。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章胜胜肽合成市场变数、趋势、范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 胜肽合成市场分析工具
    • 波特的分析
    • PESTEL分析

第四章胜肽合成市场：依产品分类的预估及趋势分析

  • 细分仪表板
  • 胜胜肽合成市场：2023 年和 2030 年按产品分類的变化分析
  • 装置
  • 试剂/耗材
  • 服务

第五章胜肽合成市场：依技术估算及趋势分析

  • 细分仪表板
  • 胜胜肽合成市场：2023 年和 2030 年技术变化分析
  • 固相胜胜肽合成（SPPS）
  • 液相胜肽合成（LPPS）
  • 混合技术

第六章胜胜肽合成市场：依应用估算及趋势分析

  • 细分仪表板
  • 胜胜肽合成市场：2023 年和 2030 年按应用分类的变化分析
  • 治疗药物
    • 癌症
    • 代谢
    • 心血管疾病
    • 呼吸系统
    • GIT（胃肠道疾病）
    • 感染疾病
    • 疼痛
    • 皮肤
    • 中枢神经系统
    • 肾
    • 其他的
  • 诊断
  • 研究

第七章胜胜肽合成市场：依最终用途分类的估算与趋势分析

  • 细分仪表板
  • 胜胜肽合成市场：2023 年和 2030 年最终用途的变化分析
  • 製药和生物技术公司
  • 合约开发和製造组织/合约研究组织
  • 学术研究所

第八章胜肽合成市场：区域估计和趋势分析

  • 胜胜肽合成市场占有率：按地区划分，2023 年和 2030 年
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 科威特

第9章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • GenScript
    • Bachem Holding AG
    • Biotage
    • Creative Diagnostics
    • PolyPeptide Group
    • Syngene International Limited
    • Puresynth Research Chemicals Pvt Ltd.
    • Lonza
简介目录
Product Code: GVR-3-68038-697-4

Peptide Synthesis Market Growth & Trends:

The global peptide synthesis market size is expected to reach USD 1.4 billion by 2030 growing at a CAGR of 12.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Significant research and innovation targeted towards the development of peptide therapeutics is set to boost the market growth in the near future. Additionally, increasing advancements in the peptide synthesis technologies is expected to offer profitable opportunities for the companies operating in the market.

A surge in the demand for custom peptide synthesis has been observed in the recent years; several companies operating in this industry offer products and services associated with custom peptide synthesis. For instance, a UK based company namely, Almac Group offers peptide synthesis suitable for research use. Constantly growing demand and evolving market landscape for custom peptides is set to offer lucrative opportunities for the market growth. The suppliers are expanding their production capacity to suffice the increasing demand for high quality peptides across research and therapeutics areas.

Rising focus of the pharmaceutical companies towards the development of novel biologics and shifting the peptide drugs from the pipeline stage to commercial scale further strengthens the market growth. Increase in the number of research activities performed on exploring the potential of high-quality peptides and peptide libraries in the development of vaccines and biomarker discovery heavily contributes to the revenue generated by the global peptide synthesis market. Moreover, introduction of modified peptides (GMP peptides) that possess enhanced stability and pharmacokinetic properties in the market is expected to maintain the double-digit market growth throughout the forecast period.

Therapeutic peptide development has witnessed remarkable growth in the recent years, this is further driven by significant increase in the patient pool suffering from cardiovascular and metabolic diseases. This has propelled the discovery of bioactive peptides exponentially which further drives the market demand.

Peptide Synthesis Market Report Highlights:

  • Reagents & consumables accounted for the highest revenue generated in 2023 and is anticipated to maintain this trend throughout the forecast period.
  • Peptide synthesis equipment has registered fastest growth during the forecast period
  • Peptide synthesizers segment serves to be a major contributor to the revenue generated by equipment in the global market and is anticipated to grow at highest CAGR of 13.6% from 2024 to 2030 among other peptide synthesis equipment.
  • Liquid phase peptide synthesis (LPPS) technology dominated the peptide synthesis market in 2023 and is expected to continue this dominance throughout the forecast period.
  • Therapeutic peptide synthesis has garnered the largest share in the market in 2023 and is anticipated to maintain this trend throughout the forecast period.
  • North America region has generated highest revenue in 2023 and is expected to maintain this dominance throughout the forecast period; sufficient presence of skilled professionals along with the strong network of peptide synthesis manufacturers is attributive to this region's dominance in the global market.
  • APAC is expected to offer lucrative opportunities for the market expansion, attributed to rising focus on the development of peptide therapeutics.
  • Large patient pool for cardiovascular and metabolic diseases in the APAC region has significantly contributed to the revenue generated, contributing to the highest CAGR registered during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Peptide Synthesis Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Peptide Synthesis Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Peptide Synthesis Market: product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Peptide Synthesis Market Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Equipment
    • 4.3.1. Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Peptide Synthesizers
      • 4.3.2.1. Peptide Synthesizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Lyophilizers
      • 4.3.3.1. Lyophilizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Chromatography Equipment
      • 4.3.4.1. Chromatography Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Others
      • 4.3.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Reagents & Consumables
    • 4.4.1. Reagents & Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Resins
      • 4.4.2.1. Resins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Amino Acids
      • 4.4.3.1. Amino Acids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Coupling Reagents
      • 4.4.4.1. Coupling Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Dyes & Fluroscent Labeling Reagents
      • 4.4.5.1. Dyes & Fluroscent Labeling reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Peptide Synthesis Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Peptide Synthesis Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Solid Phase Peptide Synthesis (SPPS)
    • 5.3.1. Solid Phase Peptide Synthesis (SPPS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Liquid Phase Peptide Synthesis (LPPS)
    • 5.4.1. Liquid Phase Peptide Synthesis (LPPS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Hybrid Technology
    • 5.5.1. Hybrid Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Peptide Synthesis Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Peptide Synthesis Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Therapeutics
    • 6.3.1. Therapeutics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Cancer
      • 6.3.2.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Metabolic
      • 6.3.3.1. Metabolic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Cardiovascular Disorder
      • 6.3.4.1. Cardiovascular Disorder Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Respiratory
      • 6.3.5.1. Respiratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. GIT (Gastrointestinal Disorders)
      • 6.3.6.1. GIT (Gastrointestinal Disorders) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Infectious Diseases
      • 6.3.7.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Pain
      • 6.3.8.1. Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Dermatology
      • 6.3.9.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.10. CNS
      • 6.3.10.1. CNS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.11. Renal
      • 6.3.11.1. Renal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.12. Others
      • 6.3.12.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Diagnosis
    • 6.4.1. Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Research
    • 6.5.1. Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Peptide Synthesis Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Peptide Synthesis Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. Pharmaceutical & Biotechnology Companies
    • 7.3.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Contract Development & Manufacturing Organization/Contract Research Organization
    • 7.4.1. Contract Development & Manufacturing Organization/Contract Research Organization Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Peptide Synthesis Market: Regional Estimates & Trend Analysis

  • 8.1. Peptide Synthesis Market Share, By Region, 2023 & 2030, USD Million
  • 8.2. North America
    • 8.2.1. North America Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Italy Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Spain Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Norway Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. China
      • 8.4.2.1. China Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Japan Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Australia Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Saudi Arabia
      • 8.6.2.1. Saudi Arabia Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. UAE
      • 8.6.3.1. UAE Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. South Africa
      • 8.6.4.1. South Africa Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific Inc.
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/Strategic Initiatives
    • 9.4.2. Merck KGaA
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/Strategic Initiatives
    • 9.4.3. GenScript
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/Strategic Initiatives
    • 9.4.4. Bachem Holding AG
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/Strategic Initiatives
    • 9.4.5. Biotage
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/Strategic Initiatives
    • 9.4.6. Creative Diagnostics
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/Strategic Initiatives
    • 9.4.7. PolyPeptide Group
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/Strategic Initiatives
    • 9.4.8. Syngene International Limited
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/Strategic Initiatives
    • 9.4.9. Puresynth Research Chemicals Pvt Ltd.
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/Strategic Initiatives
    • 9.4.10. Lonza
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/Strategic Initiatives